跳至主要内容
临床试验/NCT06656949
NCT06656949招募中不适用

A Prospective, Randomized Trial Comparing the Different Injection Sites of Indocyanine Green (ICG) in Sentinel Lymph Node Mapping in Patients With Endometrial Cancer

Qilu Hospital of Shandong University1 个研究点 分布在 1 个国家目标入组 42 人开始时间: 2024年10月30日最近更新:
适应症

试验速览

阶段
不适用
状态
招募中
入组人数
42
试验地点
1
主要终点
paraaortic Sentinel lymph node detection rates

研究概览

简要总结

The primary goal of this prospective study is to define the efficacy of the sentinel lymph node biopsy (SLNB) procedure by comparing different method performed in patients with endometrial cancer. The aim of this study is to investigate whether the detection rate of sentinel lymph node (SLN) with two different injection sites may be increased compared to the standard use with single site (cervix) injection in endometrial cancer.

详细描述

The primary treatment for endometrial cancer involves total hysterectomy and bilateral salpingo-oophorectomy, with adjuvant radiotherapy and/or chemotherapy reserved for patients with advanced disease or who have risk factors for relapse. The tumor is confined to the uterus in 85% of endometrial cancers. Hence, it's controversial to perform systematic lymphadenectomy to all patients. The primary purpose of the present study is the to investigate the feasibility of sentinel lymph node determination in endometrial cancer patients operated via conventional laparoscopy. To determine sentinel lymph nodes cervical indocyanine green will be injected prior to the surgery. During the surgery using fluorescent imaging systems sentinel lymph nodes will be removed and examined by frozen section. Afterwards, systematic pelvic lymphadenectomy will be performed if sentinel lymph node is positive.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Diagnostic
盲法
None

入排标准

年龄范围
18 Years 至 80 Years(Adult, Older Adult)
性别
Female
接受健康志愿者

入选标准

  • • 1.Age >18 and <80 years old
  • The pathological diagnosis was epithelial ovarian cancer
  • 3.Survival time is expected to exceed 3 months
  • 4.Signed consent form

排除标准

  • Patients with myocardial infarction or stroke, or unstable angina pectoris or decompensated heart function
  • 2.Patients with a history of exhaustion or deep vein thrombosis;
  • Liver insufficiency (transaminase >2.5 times the upper limit of the standard);
  • Renal insufficiency (serum muscle liver >2 times the standard upper limit);
  • Pregnancy and perinatal patients;
  • History of major organ transplantation and immune disease;
  • Psychiatric condition or language barriers
  • Alcohol or drug abuser (current or previous)
  • Unable or unwilling to sign informed consent or comply with study requirements;
  • Patients with other malignant tumors.

结局指标

主要结局

paraaortic Sentinel lymph node detection rates

时间窗: intraoperative day0

IGC positive Sentinel lymph node detection in paraaoritc lymph node will be assessed

Sentinel lymph node technique accuracy

时间窗: postoperative up to day7

Sensitivity and specificity measure of the sentinel lymph node for detecting the lymphatic metastasis

次要结局

  • Optimizing Sentinel lymph node detection procedure in endometrium cancer(intraoperative day 0)
  • The difference Sentinel lymph node detection rate with Double Injection Sites and one injection site(intraoperative day 0)
  • Postoperative complications(postoperative up to day 30)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Youzhong Zhang

chief of OB&G department

Qilu Hospital of Shandong University

研究点 (1)

Loading locations...

相似试验

Sentinel Lymph Node Mapping With Different Injection... | 临床试验